 |
L-threonyl-L-prolyl-L-prolyl-L-threonine |
|---|---|
| Trade Name | |
| Orphan Indication | Neuropathic pain associated with spinal cord injury |
| USA Market Approval | USA |
| USA Designation Date | 2005-04-26 00:00:00 |
| Sponsor | Nyxis Neurotherapies, Inc.;1801 Maple Avenue, Suite 4300;Evanston, Illinois, 60201 |
